SEC Filing Summary: Lloyds Banking Group Plc (13F-HR)
Business Context and Reporting Period
This filing is a Form 13F-HR submitted by Lloyds Banking Group Plc, an institutional investment manager based in London. The report covers the calendar quarter ended June 30, 2014, and was signed on August 14, 2014. The filing includes holdings for Lloyds Banking Group Plc and two other included managers: Clerical Medical Asset Management (Luxembourg) SA and Lloyds Bank International Limited.
Key Financial Metrics
As a Form 13F-HR, this document reports equity holdings rather than the issuer's operational financial performance. Consequently, the filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity for Lloyds Banking Group Plc itself. The only aggregate financial metric disclosed is the total value of the reported holdings:
- Total Value of Reported Holdings: $413,198,000 (reported in thousands).
- Total Number of Holdings Entries: 559.
Material Changes
The filing text does not provide comparative data against the prior quarter (March 31, 2014) or prior year periods. Therefore, material changes in portfolio composition or value cannot be determined from this document alone.
Guidance, Outlook, and Risks
This filing type does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding the business operations of Lloyds Banking Group Plc. It strictly lists securities held with voting authority or dispositive authority.
Investor Verification Checklist
- Verify the specific securities held within the 559 entries to understand the portfolio's sector exposure.
- Confirm the voting and dispositive authority for each holding, as this form distinguishes between sole, shared, and dispositive authority.
- Note that the total value ($413.2 million) represents the aggregate value of the reported portfolio, not the market capitalization or assets of Lloyds Banking Group Plc.
- Check for subsequent amendments or the next quarter's filing to analyze portfolio turnover and strategy shifts.